24/07/2014
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers from the Universitat Politècnica de Catalunya - BarcelonaTech (UPC), the Institute of Medical Chemistry (IQM-CSIC) and the University of Glasgow have proved that the CD27 drug is a true alternative against malaria. They have analysed the crystalline structure of the DNA with the drug by performing X-ray diffraction experiments at the ALBA Synchrotron. This work has been published in the journal Acta Crystallographica D.
Read the full press release published by the ALBA Synchrotron
Read the full press release published by the ALBA Synchrotron
More news
11/05/2016
How ALBA Synchrotron Can Lead to Improve Cements, Pigments, Ceramics and Glasses
05/05/2016
When Fairs Lead to ALBA and Barcelona Synchrotron Park
30/04/2016
TECNIO Entities, a Label for Entrepreneurial Innovation
22/04/2016
Barcelona Synchrotron Park Will Be at the Barcelona Innova Exhibition
15/04/2016
MIRAS Beamline at ALBA: and There Was Infrared Light
07/04/2016
Barcelona Synchrotron Park in the race